{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:03:28Z","timestamp":1753877008595,"version":"3.41.2"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","award":["541001009"],"award-info":[{"award-number":["541001009"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The acceptability of innovative medical strategies among healthcare providers and patients affects their uptake in daily clinical practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To explore experiences of healthcare providers and patients with culture-based antibiotic prophylaxis in transrectal prostate biopsy with three swab-screening scenarios: self-sampling at home, self-sampling in the hospital and sampling by a healthcare provider.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed focus group interviews with urologists and medical microbiologists from 11 hospitals and six connected clinical microbiological laboratories. We used Flottorp\u2019s comprehensive checklist for identifying determinants of practice to guide data collection and analysis. The experiences of 10 laboratory technicians from five laboratories and 452 patients from nine hospitals were assessed using a questionnaire.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, culture-based prophylaxis strategies were experienced as feasible in daily clinical practice. None of the three swab-screening scenarios performed better. For urologists (n\u200a=\u200a5), implementation depended on the effectiveness of the strategy. In addition, it was important to them that the speed of existing oncology care pathways is preserved. Medical microbiologists (n\u200a=\u200a5) and laboratory technicians (n\u200a=\u200a8) expected the strategy to be fairly easy to implement. Patients (n\u200a=\u200a430; response rate 95.1%) were generally satisfied with the screening scenario presented to them. To meet the various patients\u2019 needs and preferences, multiple scenarios within a hospital are probably needed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This multi-method study has increased our understanding of the acceptability of culture-based prophylaxis strategies in prostate biopsy, which can help healthcare providers to offer high-quality patient-centred care. The strategy seems relatively straightforward to implement as overall acceptance appears to be high.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jacamr\/dlab161","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T19:58:14Z","timestamp":1633463894000},"source":"Crossref","is-referenced-by-count":1,"title":["Acceptability of innovative culture-based antibiotic prophylaxis strategies: a multi-method study on experiences regarding transrectal prostate biopsy"],"prefix":"10.1093","volume":"3","author":[{"given":"Sofie C M","family":"Tops","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita M P","family":"Huis","sequence":"additional","affiliation":[{"name":"Scientific Center for Quality of Healthcare (IQ healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willeke","family":"Trompers","sequence":"additional","affiliation":[{"name":"Scientific Center for Quality of Healthcare (IQ healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke J M","family":"Oerlemans","sequence":"additional","affiliation":[{"name":"Scientific Center for Quality of Healthcare (IQ healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P Michiel","family":"Sedelaar","sequence":"additional","affiliation":[{"name":"Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kolwijck","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands"},{"name":"Department of Medical Microbiology, Jeroen Bosch Hospital, \u2019s-Hertogenbosch, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiman F L","family":"Wertheim","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies E J L","family":"Hulscher","sequence":"additional","affiliation":[{"name":"Scientific Center for Quality of Healthcare (IQ healthcare), Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"2021111805211940500_dlab161-B1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"2021111805211940500_dlab161-B2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12879-017-2470-1","article-title":"Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial","volume":"17","author":"Zembower","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2021111805211940500_dlab161-B3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bju.13402","article-title":"The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review","volume":"117","author":"Cussans","year":"2016","journal-title":"BJU Int"},{"year":"2019","author":"Mottet","key":"2021111805211940500_dlab161-B4"},{"key":"2021111805211940500_dlab161-B5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","article-title":"Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study","volume":"63","author":"Wagenlehner","year":"2013","journal-title":"Eur Urol"},{"key":"2021111805211940500_dlab161-B6","doi-asserted-by":"crossref","first-page":"5392107","DOI":"10.1155\/2016\/5392107","article-title":"Prevalence, risk factors, and clinical relevance of fluoroquinolone-resistant organisms in rectal cultures: should we target antibiotic prophylaxis prior to prostate biopsy?","volume":"2016","author":"Van Besien","year":"2016","journal-title":"Adv Urol"},{"key":"2021111805211940500_dlab161-B7","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.eururo.2008.03.033","article-title":"Antibiotic prophylaxis in urologic procedures: a systematic review","volume":"54","author":"Bootsma","year":"2008","journal-title":"Eur Urol"},{"year":"2003","author":"Verburgh","key":"2021111805211940500_dlab161-B8"},{"author":"de Greeff","key":"2021111805211940500_dlab161-B9"},{"key":"2021111805211940500_dlab161-B10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00345-018-2217-7","article-title":"The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis","volume":"36","author":"Scott","year":"2018","journal-title":"World J Urol"},{"key":"2021111805211940500_dlab161-B11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/JU.0000000000000814","article-title":"Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-Analysis","volume":"204","author":"Pilatz","year":"2020","journal-title":"J Urol"},{"key":"2021111805211940500_dlab161-B12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/aam.aam_48_18","article-title":"A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy","volume":"18","author":"Doherty","year":"2019","journal-title":"Ann Afr Med"},{"key":"2021111805211940500_dlab161-B13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2021111805211940500_dlab161-B14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1748-5908-8-35","article-title":"A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice","volume":"8","author":"Flottorp","year":"2013","journal-title":"Implement Sci"},{"key":"2021111805211940500_dlab161-B15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2019.04.025","article-title":"Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands","volume":"125","author":"Polman","year":"2019","journal-title":"Prev Med"},{"key":"2021111805211940500_dlab161-B16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijgo.2014.02.026","article-title":"Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador","volume":"126","author":"Rosenbaum","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"2021111805211940500_dlab161-B17","doi-asserted-by":"crossref","first-page":"e0132776","DOI":"10.1371\/journal.pone.0132776","article-title":"Self-collected versus clinician-collected sampling for chlamydia and gonorrhea screening: a systemic review and meta-analysis","volume":"10","author":"Lunny","year":"2015","journal-title":"PLoS One"},{"key":"2021111805211940500_dlab161-B18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000452710","article-title":"Feasibility and acceptability of anal self-sampling for human papillomavirus screening in HIV-infected patients","volume":"59","author":"Tamalet","year":"2016","journal-title":"Intervirology"},{"key":"2021111805211940500_dlab161-B19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1701-2163(16)32337-4","article-title":"Self-sampling for group B streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable: a randomized cross-over trial","volume":"28","author":"Price","year":"2006","journal-title":"J Obstet Gynaecol Can"}],"container-title":["JAC-Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/4\/dlab161\/41162104\/dlab161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jacamr\/article-pdf\/3\/4\/dlab161\/41162104\/dlab161.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T08:10:01Z","timestamp":1637223001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jacamr\/article\/doi\/10.1093\/jacamr\/dlab161\/6429829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/jacamr\/dlab161","relation":{},"ISSN":["2632-1823"],"issn-type":[{"type":"electronic","value":"2632-1823"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,9,30]]},"article-number":"dlab161"}}